![Macitentan n-butyl analogue Size:Solid 10 mg [Epub ahead of print] PubMed](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M11193_1621563144.gif?v=1621563146)
Pay in 4 interest-free payments of $28.75 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
[Epub ahead of print] PubMed PMID: 29299572
CAS Number: 86541-74-4
Pre-treatment of AML cells with IPI-145 inhibits both adhesion and migration of AML blasts to bone marrow stromal cells
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest
Macitentan n-butyl analogue Size:Solid 10 mg [Epub ahead of print] PubMedMacitentan n butyl analogue is a n butyl analogue of Macitentan. Macitentan is an orally active, non peptide dual endothelin ETA and ETB receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). Product information CAS Number: 556797 16 1 Molecular Weight: 587. 28 Formula: C20H21Br2N5O4S Chemical Name: N [5 (4 bromophenyl) 6 {2 [(5 bromopyrimidin 2 yl)oxy]ethoxy}pyrimidin 4
US$ 145.00
US$ 149.57
US$ 154.50
US$ 40.00
US$ 32.00